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ABSTRACT 
Qingwei Liu: Local Brain Temperature Manipulation System and Physiological 
Parameters (R2', CBF and ADC) Measurements in Acute Stroke 
(Under the direction of Weili Lin) 
 
 
Accurate prediction of final lesion is critically important for clinical decision 
making in the management of acute ischemia stroke patients. In addition to the widely 
utilized perfusion and diffusion parameters, an MR derived cerebral oxygen 
metabolism index OMI_ R2′, may be a potential candidate for infarction prediction.  
In this study, we evaluated how these MR parameters may delineate infarction in rats 
with ischemic injury.   
There is overwhelming evidence from animal studies showing that cooling may 
improve outcome after cerebral ischemia. However, how physiology parameters 
during ischemic injury are modulated by brain temperature is largely unknown.  In 
this study, we designed an MR compatible focal brain temperature manipulation 
system, which can regulate brain temperature accurately. The relationship between T1 
and temperature in brain tissue was investigated, which can be used to derive the brain 
temperature under hypothermic conditions. The relationship between CBF and 
temperature was also studied under ischemic condition. 
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CHAPTER 1 
 
INTRODUCTION 
 
 
Magnetic Resonance Imaging (MRI) has become a widely used and powerful imaging 
modality because of its flexibility, sensitivity to broad range of tissue properties and 
noninvasive nature. Due to the complexity of signal formation, MRI provides not only 
anatomic information, but also information of brain function and other biological 
homodynamic processes, such as Cerebral Blood Flow (CBF)[1], Cerebral Blood Volume 
(CBV), etc. With MRI, a better understanding of the relationships among brain structure, 
function, and pathology is feasible. 
 
1.1 Backgrounds 
Stroke is a global health problem affecting approximately 750,000 people annually in the 
United States alone and ranks as the third leading cause of death and the most common cause 
of disability in most developed countries. Based on the underlying causes, strokes can be 
classified into two major categories: ischemic and hemorrhagic stroke. Ischemia is due to 
interruption of the blood supply to part of the brain tissue, leading to dysfunction and necrosis 
of the brain tissue in that area, while hemorrhage is due to rupture of a blood vessel or an 
abnormal vascular structure. About 87% of strokes are due to ischemia and the rest are due to 
hemorrhage.  
Until now, intravenous administration of Tissue Plasminogen Activator (tPA), which is 
used to dissolve the clot and unblock the artery, is the only FDA approved therapy for the 
treatment of acute ischemic stroke patients. In the National Institute of Neurological Disorders 
and Stroke trial (NINDS)[2], patients treated with t-PA were at least 30 percent more likely to 
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have minimal or no disability at three months on the assessment scales as compared with 
patients received placebo. Symptomatic intracerebral hemorrhage within 36 hours after the 
onset of stroke occurred in 6.4 percent of patients given t-PA but 0.6 percent of patients given 
placebo (P <0.001). The mortality rate in cases of symptomatic ICH was 47% but the global 
mortality rate was lower in the tPA group than in the placebo group (17% vs. 21%) because of 
a reduction in death not related to hemorrhage. The pooled analysis of four large placebo 
controlled trials (NINDS, ECASS, ECASSII, ATLANTIS) involving 3000 patients showed 
intravenous tPA (when given within the 3 hour window) resulted in improved clinical 
outcomes with a relative risk reduction of about 9.8% for achieving minimal or no disability at 
3 months.[3-5] Although the control studies show that intravenous tPA is effective and safe 
when given under restrictive conditions within 3 hours after stroke onset, the data for a longer 
therapeutic window, between 3 and 6 hours remain controversial. The expected functional 
improvement and the risk of intracranial hemorrhage greatly depend on selective clinical and 
imaging criteria[6]. It is recommended by the American Heart Association and the American 
Academy of Neurology that tPA should be administrated for acute ischemic stroke within 3 
hours of onset of symptoms[2] while there are no other contraindications (such as abnormal 
lab values, high blood pressure, or recent surgery). Recently the Third European Cooperative 
Acute Stroke Study (ECASS-3) demonstrated a benefit of treatment for acute stroke even until 
4.5 hours after onset of occlusion.[7] Since thrombolysis is not beneficial for all stroke 
patients, strict criteria should be applied before treatment. As time from symptom onset 
increases, the need for careful patient selection also increases. 
Since the therapeutic window for tPA is short, only a small percent of patients are eligible 
for treatment. To alleviate this problem, two potential approaches have been proposed 1) 
identifying the sub-group of patients who may benefit from tPA injection beyond 3 hours 
therapeutic window; and 2) utilizing a neuroprotective method to prolong the survive window 
of neurons under ischemic condition.  
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For the former approach, MR perfusion-diffusion mismatch has been a popular method in 
clinic to predict the salvable area in the brain. Although promising results have been shown, 
the validity of this approach is still under extensive scrutiny [8-13]. It was found that the 
diffusion lesion can reverse after reperfusion, while perfusion deficit cannot differentiate 
benign oligemia from penumbra. In contrast, it has been demonstrated that measures of 
cerebral metabolic rate of oxygen utilization may provide more accurate insights into tissue 
viability [14-17].  
For the second approach, hypothermia is a potential candidate to extend the therapeutic 
window. The neuroprotective properties of mild hypothermia have been demonstrated in 
numerous experimental animal models[18, 19] and human studies[20], with significant 
improvement of ischemic stroke outcome. Hypothermia is more efficient than other methods 
because it can affect a wide range of cell death mechanisms simultaneously. Although 
hypothermia therapy is promising, there is no conclusion yet on the optimal duration, depth 
and the time of onset of hypothermia for ischemic stroke. Since different conditions may lead 
to very different results, it is imperative to address how hypothermia extends the therapeutic 
window. In this study, we focused on how brain tissue viability is modulated by brain 
temperature.   
The following relevant background information to this study is provided. 
 
1.1.1 Viable Tissue or Irreversible Damage 
Ischemia is caused by a shortage of blood supply to an organ. Tissue is deprived of 
oxygen and other nutrition under ischemia.  Based on the severity of ischemia and the elapsed 
time after ischemic onset, tissue can be potentially classified into ischemic core, penumbra 
and oligemia.  Ischemic core, often referred to as irreversible ischemic injury, loses not only 
its electrical functions but also structural integrity. It will die regardless of any treatment. 
Ischemic penumbra, defined as a region exhibiting impaired electrical activity, but preserved 
morphologic integrity, cellular metabolism and viability [21-25]. Ischemic penumbra may be 
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salvaged by an effective treatment. The presence of penumbra is an evolving process 
depending on both the ischemic severity and the elapsed time since ischemic onset [26-29]. 
Several studies have demonstrated that salvageable tissue may still exist even beyond the 3 
hours time window [27, 30-32]. Therefore, a means to delineate irreversible and reversible 
cerebral ischemic injuries may aid to select patients who may benefit from the tPA treatment 
even beyond the currently approved 3 hour window.  Oligemia is the region with mild flow 
deficit and it can survive even without any treatment.  
The mismatch between MR diffusion and perfusion images  has been suggested to provide 
an estimate of the ischemic penumbra and is used in clinic within the first 6 hour after stroke 
onset to select patients who might benefit from thrombolysis.[33] Although promising results 
have been shown, this approach has been thought to be overly simplified and the validity of 
this approach is still under studied [8-13]. Recent findings indicate that the subtraction of the 
ischemic lesion on diffusion-weighted imaging (DWI) from the abnormality on perfusion-
weighted imaging (PWI) is only a weak approximation of the penumbra.[8] The DWI defined 
ischemic core region often overestimates the final infarction volume, since it was found that 
the diffusion lesion can be recovered after reperfusion[34]. We have observed similar results 
in our study, with DWI lesion larger than the final lesion defined using T2 weighted images, 
especially with a short period of occlusion time, e.g. 45 minutes. In addition, the MR 
perfusion deficit is not reliable either since it cannot differentiate benign oligemia from the 
penumbra[8], thus making that the mismatch overestimates the penumbra. 
In contrast, it has been demonstrated that measures of cerebral metabolic rate of oxygen 
utilization may provide more accurate insights into tissue viability [14-17]. During the process 
of cerebral oxygen metabolism, paramagnetic deoxyhemoglobins (deoxy-Hb) are present in 
capillaries and veins. The concentration of deoxy-Hb thus reflects oxygen extraction fraction 
(OEF) . Therefore, the measurements of  R2′, which is proportional to the concentration of 
deoxy-Hb, could potentially be used to indirectly estimate OEF.  To evaluate whether R2′ may 
provide additional information concerning the metabolic state of ischemic tissue, Geisler et al 
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examined R2′ in regions with abnormal apparent diffusion coefficient (ADC). They observed 
an elevated R2′ in the ischemic hemisphere when compared to the unaffected hemisphere.  
Moreover, the increase of R2′ is highest in ADC lesion, followed by the lesion growth and 
surviving regions.  Their observation suggested that an increase of R2′ may correspond to an 
increase of OEF in ischemia.  More recently, Siemonsen et al have reported that R2′ > ADC 
mismatch is a more specific predictor of infarct growth than is TTP >ADC mismatch in 
thrombolytic treated patients. These findings are encouraging and may reveal the clinical 
utility of R2′ in acute stroke.  Similar to the PET measured OEF, R2′ only reflects the oxygen 
metabolic demand.  It has been suggested in the PET literature that cerebral metabolic rate of 
oxygen (CMRO2),  which reflects the balance between oxygen delivery (CBF) and demand 
(OEF), may be a more specific marker for tissue viability.  Although quantitative measures of 
CMRO2 can be derived using PET, an MR based approach, if proven to be capable of 
providing similar information on oxygen metabolism, may greatly facilitate routine clinical 
application.  In line with the findings in PET literature, an MR derived cerebral oxygen 
metabolism index, which is a product of CBF and R2′ (OMI_ R2′), might be able to separate 
penumbra from irreversible core. 
   
1.1.2 Neuroprotective Effects of Hypothermia 
Hypothermia has been proved to improve the outcome of acute cerebral ischemia in 
laboratory animals[18, 19].  In humans, hypothermia is an established tool for the protection 
of brain tissue during surgery and it seems to improve the outcome of patients, who have 
suffered an acute ischemic stroke [20]. At normal temperature, brain tissue at risk cannot 
survive when the metabolic variables decline below a specific threshold [5–7]. The duration of 
this decline is often referred to as the critical time window of therapeutics. For ischemic 
stroke, the critical time-window of 3 hours is too narrow for most of the stroke patients to 
receive tPA.  One alternative may be to combine tPA with hypothermia so as to extending the 
therapeutic window of tPA [7–9]. Thus, both the time of initiating the cooling and the 
6 
 
subsequent duration of hypothermia play important roles in determining the efficacy of this 
treatment.  
Pre-clinical studies have suggested that hypothermia affects a wide range of cell death 
mechanisms including reduction of the cerebral oxygenation and energy metabolic activities 
[35-39], alteration in oxygen free radicals release [40-44], decreases in the release of 
excitotoxic neurotransmitters [45-47], reduction or delay in apoptosis [48-50], and 
preservation of the blood-brain barrier [51-54].  The potential of hypothermia has recently 
been underlined by randomized clinical trials in patients with global cerebral ischemia after 
cardiac arrest[55]  and in infants with moderate or severe hypoxic-ischemic encephalopathy 
[56], in which cooling reduced mortality and disability. In addition, several prospective 
observational studies have demonstrated that higher body temperatures are associated with 
poor outcome after stroke[20, 57].  In animal focal ischemia models, hypothermia reduces 
infarct size by 44% [95% confidence interval (CI), 40-47%][58], with the highest efficacy 
obtained with cooling to a lower temperature (<=31 ). The effect of cooling was most robust 
when started before or at the start of vessel occlusion, but there was no clear time-dependency 
thereafter. The efficacy was higher in transient than in permanent occlusion models, but the 
effect in the latter was still substantial (37%; 95% CI). In addition, hypothermia significantly 
improves the survival rate, which is in accordance with data from the MCA occlusion model 
even for delayed application and reperfusion[54]. Although hypothermia therapy is promising, 
there is no conclusion yet on the optimal duration, depth of cooling and the time of onset of 
hypothermia. Thus, a more thorough investigation of the mechanisms of how hypothermia 
benefits the ischemic stroke may provide theoretical basis to extend the therapeutic window.  
At present, systemic surface cooling is the most widely used method to induce and 
maintain mild hypothermia. Although these methods are effective, the decreased body 
temperature can lead to multiple side effects, such as pneumonia, arterial hypotension, 
thrombocytopenia, bradycardia, infection and myocardial infarctions, [59-63]. Instead, 
selective brain cooling methods can induce hypothermia in the brain locally, while 
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maintaining the body temperature within the normal range, which could suppress the side 
effects. In this study, we designed an MR compatible local brain temperature manipulation 
system, which is able to regulate brain temperature consistently and accurately for a desired 
period of time, while keeping the body temperature within normal range. Using this local 
brain cooling device, we studied the relationship between cerebral perfusion and brain 
temperature in ischemic stroke as well. 
 
1.1.3 Brain Temperature Mapping 
It has been suggested that the brain is sensitive to temperature alterations [64-66].  A 
small decrease in brain temperature by only a few degrees leads to significant neuro-
protective effects in ischemic stroke, while a slightly increased brain temperature exacerbates 
brain injury[19, 48, 51, 64, 66-77].  In order to evaluate how temperature alters brain 
metabolism, an accurate measurement of brain temperature is important.  A direct 
measurement of brain temperature with a temperature probe is invasive and cannot provide 
spatially resolved information. In recent global cerebral ischemia and head injury rodent 
studies, the temperature in temporal muscle was measured to represent the brain temperature. 
However, it has been reported that the temperature in temporal muscle is different from the 
brain temperature. There are also studies reporting that the temperature in temporal muscle 
was markedly lower than brain in rats during ischemic condition with the MCAO model.  
In addition, with the local surface cooling method, where there is a large temperature 
gradient inside the brain, it is not possible for a single temperature probe to reflect the spatial 
temperature information. Therefore, a pixel-by-pixel brain temperature map is desirable to 
reliably reveal the potential relation between brain temperature and other physiological 
parameters.  
 
1.2 Accomplishment  
The accomplishments in this study are listed as below. 
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1. We developed an MR compatible device which can manipulate local brain temperature 
accurately and maintain for a desired period of time, while preserving a normal systemic body 
temperature and other physiology parameters. 
2. The relationship between T1 and temperature in the brain was derived.  
3. The relationship between CBF and temperature was derived at different severity of 
ischemic stroke regions. 
4. A GESSE sequence was applied to measure R2’, with a multi-navigator echo method 
for motion correction and the Z-shimming method for B0 field inhomogeneity correction. 
5. The relationship between different MR parameters (ADC, CBF, R2’ and OMI_R2) in 
rats with a short duration of ischemic injury (45 minutes MCAO) was studied. 
  
 
 
 
CHAPTER 2 
MR COMPATIBLE LOCAL COOLING DEVICE 
DESIGN AND STUDY OF RELATIONSHIP 
BETWEEN CEREBRAL BLOOD FLOW AND T1 
WITH TEMPERATURE 
 
2.1 Theory: Relevant MR Principals and Instrumentation Concepts 
 
The purpose of this chapter is to introduce the relevant MR principles related to the study, 
and instrument design concepts. 
 
2.1.1 Magnetization, Relaxation and the Bloch Equation 
 
2.1.1.1 MR Signal Formation 
 
MRI is based on the interaction between proton spin and the external magnetic field, B0. 
The dominant nucleus in MRI is the proton in hydrogen.  Its interaction with the external field 
results in the precession of the proton spin about the field direction. The procession angular 
frequency for the proton magnetic moment vector is given by 
00 .B

      (2.1) 
where is the Lamar Frequency, B0 is the main (external) magnetic field strength in 
Tesla,   is the gyromagnetic ratio, a constant equals to 2.675x10e8 rad/T/sec for proton. 
In order to generate a detectable signal by the receiving coil, the magnetization vector 
must be tipped away from the external field direction. The magnetic field produced by the 
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proton spins yields a changing magnetization flux in the nearby coil.  According to the 
Faraday’s law, the electromotive force ( emf ) would be induced by the change of 
magnetization flux. 
 rdBMdt
d
emf rf
3).(

    (2.2) 
Then, the induced emf is amplified and transferred into signal and eventually be 
reconstructed into an image. 
 
2.1.1.2 T2, T1, T2’ Relaxation,  B0 Inhomogeneity and Bloch Equation 
 
In an idealized system, all protons have the same precession frequency . 
However, the B0 field is never uniform in real system, which leads to a distribution of 
resonance frequencies. Over time, this distribution can lead to a dispersion of magnetic spin 
vectors, which induce the loss of signal.  
Based on the scale relative to voxel size, the B0 field inhomogeneity can be divided into 
three scales, the microscopic, mesoscopic and macroscopic levels.  
The microscopic inhomogeneities, with a size at the proton diffusion distance level, 
induce irreversible signal decay, which is represented by T2 relaxation. Spins experience local 
fields which are the combinations of the applied field and the fields of their neighbors. The 
local microscopic field inhomogeneities cause the spins to fan out in time leading to a 
reduction of net magnetization, called ‘dephasing’. Several physical factors can cause the 
reduction of transverse magnetization. For instance, motion of molecules whose electrons 
produce local fields varies as a function of time. 
The macroscopic inhomogeneity, with a size similar or larger than image voxel size, 
contributes to the reversible relaxation (T2’ relaxation). Macroscopic field inhomogeneities 
usually come from magnet imperfections, such as body-air interfaces, large sinuses inside the 
body, etc. These B0 inhomogeneities are mostly undesirable because they generally provide 
no useful information of physiologic or anatomic interest. Rather, they lead to signal loss in 
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gradient-echo (GE) imaging, and image spatial distortions in both GRE and spin-echo (SE) 
imaging. The dephasing effect of macroscopic B0 inhomogeneities are time independent and 
the signal loss can be reverted by a 180-degree RF pulse in a SE sequence. 
The mesoscopic inhomogeneity, with a size between the previous two scales, is also 
reversible and contributes to T2’ relaxation. The blood vessel network in brain tissue creates 
mesoscopic field inhomogeneities that are tissue specific and are responsible for the Blood 
Oxygenation Level Dependent (BOLD) contrast. It is well known that as the oxygen content 
in blood changes, the local susceptibility in the blood also changes. The reason is because the 
deoxyghemoglobin in the blood vessels is paramagnetic and it affects the R2’ relaxation 
constant. Thus the R2’ value can be used to reflect the concentration level of 
deoxyhemoglobin in blood vessels, and further reflect the oxygenation in the blood. 
The combined transverse relaxation time constant is represented by T2*, which is 
generally given as: 
              (2.3) 
For most magnetic resonance experiments, these "relaxations" dominate the signal decay. 
T1 relaxation is due to the interactions of the spins with their surroundings. After the 
magnetization has been rotated into the transverse plane, it will tend to grow back to along the 
direction of the static field B0. The rate of the regrowth can be characterized by a time 
constant T1, which is also called ‘spin-lattice’ relaxation time. 
The Bloch equation is used to describe the interaction of a nuclear spin with an external 
magnetic field and its local environment when T1 and T2 relaxation are considered. 
       (2.4) 
The solutions are given as, 
      (2.5) 
     (2.6) 
       (2.7) 
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From the solutions we can see, the transverse component of magnetization  is rotating in 
the x-y plane with a decay time constant T2, where rotation frequency  is the Larmor 
frequency. At the same time, its longitudinal component returns back to initial Magnetization 
 with the relaxation time constant T1. 
 
2.1.1.3 TOMROP Method for Measurement of T1 
 
There are several ways to measure T1 relaxation time. The fast T One by Multiple Read 
Out Pulses (TOMROP) sequence[78] was utilized in our study. Here is a simple description of 
this method. 
 
 
As shown in figure 1, a selective RF pulse with a flip angle  (usually 180 degree) sets 
the longitudinal magnetization to the negative direction; then a series of interrogation 
pulses with a small flip angle  is applied to create a set of gradient echoes. The time between 
interrogating pulses as well as interrogating precession angles are chosen to be a constant. 
After acquisition of each gradient echo, the remaining transversal magnetization is destroyed 
by a spoiler gradient. The signal acquired at the nth echo can be derived as below, 
Figure 1. Diagram of Look-locker sequence for measurements of T1 
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      (2.8a) 
          (2.8b) 
      (2.8c) 
             (2.8d) 
where T2* is the characteristic decay constant of the FID and  is the time between the 
interrogation pulse and data acquisition, )/exp( 1TtE rr   )/exp( 122 TTIE   and 
)cos( c . TI is the time between  and  RF pulses.  is the longitudinal 
magnetization right after the nth RF pulse, and  is a constant depending on the small RF flip 
angle . By fitting the experimental data set using equation (2.8), the 1T  value can be derived.  
 
2.1.2 Relationship Between T1 and Temperature 
 
Spin-lattice relaxation time (T1) has been demonstrated to be linearly proportional to 
temperature when it is below 45°C [79-81]. This linear temperature dependence relationship 
of T1 with temperature T can be expressed as  
 
1 1 ( )ref refT T m T T             (2.9) 
where m is the coefficient constant, and T are the reference temperature (37 ) and 
current temperature, respectively.   is the T1 value at the reference temperature.  
 
2.1.3 Cerebral Blood Flow (CBF)  
 
Tissue function depends heavily on perfusion, a process that brings nutritive blood supply 
and oxygen to the tissue through the arterial supply. There are at least two MRI methods can 
provide the measures of CBF, Dynamic Susceptibility Contrast (DSC) method and Arterial 
Spin Labeling (ASL) method. The advantage of ASL is that it uses endogenous labeled water 
proton as the contrast agent, while the DSC method uses exogenous paramagnetic contrast 
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agent instead.  The ASL method is non-invasive and can be used to measure CBF repeatedly. 
In the first part of this study, the Continuous ASL (CASL) method was used to measure the 
blood flow, while DSC method was employed in the second part of the study. 
 
 
An MR image can be used to measure the inflow of blood spins if those spins are in a 
different magnetic state compared to the static tissue. For the CASL method, the water proton 
was magnetically inverted (tagged, labeled) with a long RF pulse before entering the imaging 
slice of interest, as shown in the figure 2. The labeled arterial spins mix with the stationary 
spins in the imaging slice, reducing the signal intensity. Compared to the label procedure, a 
control image was acquired with the same RF pulse applied on a plane on the opposite side of 
imaging plane with the same distance. The difference between the labeled and control images 
can be used to evaluate blood flow. The derivation of CBF from the CASL is shown by 
Calamante et al’s [82] as.  
         (2.10a) 
where the f is the blood flow (CBF) and it can be derived as, 
aac
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   (2.10b) 
where (0.41)  is the longitudinal relaxation rate of blood at 9.4T, is the equilibrium 
magnetization of brain,  is the signal difference between labeled and control images, 
Figure 2. Continuous arterial spin labeling for measurement of CBF 
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 (0.96) is the tagging efficiency , t is the delay time between end of RF pulse and start of 
excitation, and  (0.9) is blood/tissue water partition coefficient.  
 
2.1.4 Instrumentation Basics 
 
A local brain temperature manipulation system which can manipulate the brain 
temperature accurately and quickly is necessary for our hypothermia studies. 
The local brain temperature manipulation device is composed of four units: a center 
control unit, which is realized by the BASIC Stamp Chip and related circuit; the A/D&D/A 
interface unit, which is realized by TLV5616C and TLC2543 chips; the optical 
communication interface circuit; and Relay and Pump Control unit. For the MR compatible 
consideration, the device was separated into two parts. The cooling and heating unit is placed 
inside the MR scanner room, while the electrical control units are placed outside. The optical 
signal communication was utilized between the two units. 
The BASIC STAMP is a microcontroller with a small, specialized BASIC interpreter 
(PBASIC) built into Read Only Memory (ROM). STAMP can be seen as a small computer, 
with limited memory, computing ability and interfaces. It provides 12 digital output ports and 
input ports, which can be used to communicate with other digital devices.  
TLV5616 is a 12-bit voltage output digital-to-analog converter (DAC) with a flexible 4-
wire serial interface. The 4-wire serial interface allows glueless interface to several kinds of 
serial ports. The TLV5616 is programmed with a 16-bit serial string containing 4 control and 
12 data bits.  
TLC2543 is a 12-bit switched-capacitor, successive-approximation, analog-to-digital 
converters. Each device, with three control inputs, the input-output clock, and the address 
input is designed for communication with the serial port of a host processor or peripheral 
through a serial 3-state output. The device allows high-speed data transfers from the host. 
The optical communication interface circuit was composed of optical-electric converter, 
comparator, inverter, amplifier and driver, LED light, optical fiber, etc. It converts the 
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electrical digital signal to optical signal and provides the communication between the units 
inside and outside the MR scanner room. 
The Relay and Pump Control circuit was composed of D/A converter, amplifier, driver 
and Relay (Pump). It converts the digital command to analog signal to control the relay and 
pumps. 
 
2.2 Methods and Design 
 
 
2.2.1 Animal Surgery Protocols  
 
In this study, MCAO model was used to induce stroke and reperfusion. Adult male Long-
Evans rats (280-350g) were used for all proposed studies.  The animals were anesthetized with 
isoflurane (inhaled, 5% induction, and 1.5% maintenance).  Thermal stability (370.50C) was 
maintained with a servo-controlled water pad connected to a rectal thermometer during 
surgery.  Surgical procedures for the intraluminal suture model are similar to that described in 
[83]. Under general anesthesia, local anesthesia (2% lidocaine hydrochloride) is applied by 
sub-dermal infiltration of the skin and musculature of the ventral cervical region.  The right 
common Carotid Artery (CCA) and External Carotid Artery (ECA) are exposed through a 
ventral midline incision.  The right proximal ECA is then be ligated permanently.  A 4-0 
nylon monofilament with its tip coated by silicone is inserted through an arteriotomy of the 
CCA approximately 3mm below the carotid bifurcation.  The suture is secured but can be 
freely advanced.  The incision is closed.  The animals are moved into the MR scanner room.  
After acquiring baseline images, the suture is advanced into the internal carotid artery roughly 
20-22 mm until resistance is felt while animals are lying inside the scanner. The continuous 
different MR sequences are run for the desired time. Reperfusion is achieved by carefully 
withdrawing the suture from the origin of Middle Cerebral Artery (MCA)/Anterior Cerebral 
Artery (ACA).  
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2.2.2 Local Temperature Manipulation Instrument Design 
 
To manipulate the brain temperature, while maintaining a normal body temperature, an 
MR compatible temperature manipulation device was devised and the diagram is shown in 
figure 3.  
 
 
The MR compatible temperature manipulation device controls the brain and body 
temperatures separately and simultaneously.  The brain temperature manipulation component 
consists of a tubing coil, which wraps around the head of the rat, a feed-back control unit and 
an MR-compatible peristaltic pump (SCI400D/U1, Watson Marlow Inc.).  Water circulating 
in the tubing coil was driven by the peristaltic pump.  Hypothermia and hyperthermia were 
induced by using either icy (4°C) or warm water (52°C), respectively.  Brain temperature 
measured with a fiber-optic thermo-probe (Luxtron Inc, Santa Clara, CA) inserted into the 
brain at a depth of 4.0 mm was utilized by the feedback control unit to adjust the flow rate of 
the pump so as to induce or maintain the targeted temperature.  The body temperature was 
maintained through a separate feed-back control of the heating pad, which wrapped around the 
animal body, and a pump. The core body temperature reading from a thermo-probe inserted 
4.0cm into the rectum was used as the feedback signal to maintain the desired body 
temperature at 37.5±0.5°C by switching the pump on or off. Normothermic condition in the 
Figure 3. The diagram of the local temperature manipulation system 
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brain was achieved by adjusting the core body temperature to the normal physiological range 
with the heating pad.  
The key components of the system are the control unit and A/D & D/A interface circuit, 
together with optical communication interface circuit and relay control circuit. A diagram of 
the Control units, interface circuit and optical communication circuit are shown in figure 4a to 
figure 4d. 
 
 
Figure 4a. The Control Unit 
 
Figure 4b. Optical Receiver 
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Figure 4c. Optical Transmitter 
 
 
 
 
 
 
2.2.3 Temperature Manipulation, Measurements of Relationship Between T1 
Relaxation vs. Brain Temperature, CBF vs. Temperature, and  Temporal 
Muscle Temperature vs. Brain Temperature 
 
A total of 16 rats were studied and these rats were divided into three groups. Rats in the 
first group (n=9, 300±25g) were employed to determine the effectiveness of brain temperature 
manipulation using the devised system.  Five different brain temperature manipulations, 
Figure 4d. Relay and PUMP control Circuit 
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hyperthermia (39°C), normothermia (37°C), hypothermia (35°C and 32°C) and a three-phase 
hypothermia (29°C, 32°C and 35°C) were conducted in each rat.  For the three-phase 
hypothermic condition, the brain temperature was first cooled down to 29°C, maintained for 
30 minutes, rewarmed to 32°C, maintained for another 30 minutes, rewarmed to 35°C and 
maintained for 30 minutes. For the second group of rats (n=5, 300±25g), cerebral ischemia 
was induced using an intraluminal suture Middle Cerebral Artery Occlusion (MCAO) model 
under the normothermic condition for 40 minutes, followed by the induction of three different 
hypothermic conditions, including 35°C, 33°C and 31°C. In addition, Mean Arterial Blood 
Pressure (MABP) and Heart Beat Rate (HBR) were recorded through a femoral artery catheter 
with a blood pressure analyzer (Micro-Med, Louisville, KY). In order to determine how 
hypothermia affects cerebral perfusion, ADC and CBF maps were acquired at each 
temperature point. A segmented SE EPI DWI sequence and a continuous arterial spin labeling 
(CASL) sequence with segmented EPI readout were used to obtain ADC and CBF maps, 
respectively.  Finally, for the sham operated group (n=2, 300±25g), a similar experimental 
procedure without occluding MCA was performed. The imaging parameters for the segmented 
SE DWI EPI were as follows: FOV= 45 x 45 cm, 114 x 128 matrix, TR= 1200 ms, bandwidth 
592Hz/pixel, and slice thickness 2mm and the imaging parameters for the CASL were: FOV= 
45 x 45 cm, 60 x 64 matrix, TR= 3000 ms , bandwidth 1116Hz/pixel, and slice thickness 2mm. 
For the ischemic rats (Group 2), three ROIs (core, mismatched and contra) were manually 
determined based on ADC and CBF maps. The core region was defined as the regions with 
ADC abnormalities (<mean-3*SD of the contra-lateral hemisphere). The mismatched region 
was defined as the hypoperfused region without the ADC lesion in the ipsilateral hemisphere. 
A mirror ROI in the contralateral hemisphere was chosen as the contra ROI. In contrast, an 
ROI encompassing both hemispheres excluding the region at a proximity to the temperature 
probe was outlined as sham ROI for rats in Group 3.   
To study the relationship between T1 and brain temperature, 5 Long Evan rats were 
studied. Different brain temperature was induced with our MR compatible temperature 
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manipulation system.  The brain temperature was manipulated from 37  to 35, 32 and 29  
sequentially. The temperature was maintained at each hypothermia level for 20 minutes and 
the Look-locker sequences were acquired. A thermo probe is inserted into the brain with a 
depth of 4.0mm for a direct temperature measurement.  T1 maps were calculated with the 
approach outlined in the theory section.  Since the insertion of a thermo-probe may cause 
brain tissue damage and result in potential signal variation in T1 maps, an ROI placed at a 
similar location in the contra-lateral hemisphere is used for estimating T1.  We assume that 
the brain temperature gradient caused by the surface temperature regulation is similar in both 
hemispheres.  A linear correlation between the mean T1 from the ROI and thermo-probe 
measurement was determined.   
To study the relationship between the temperature in the temporal muscle and brain, 9 
normal rats (280-330g) were used for testing. The same procedures outlined above for local 
cooling of the brain to 32  were used.  An additional optical thermal probe was inserted 
10mm into the cleft between skull and temporal muscle. The temperature of brain and 
temporal muscle were recorded simultaneously for 90 minutes after the temperature becomes 
stable. 
 
2.3 Experimental Results 
 
 
2.3.1 Local Brain Temperature Manipulation 
As shown in the results below, our MR compatible local brain temperature manipulation 
device achieves the targeted brain temperature within 10 minutes and maintains it for 90 
minutes.  As demonstrated in left diagram in figure 5, five different levels of targeted 
temperatures (39°C, 37°C, 35°C, 32°C and 29°C) were achieved promptly (< 10 minutes) and 
maintained for 90-120 minutes with a small variation (<0.5°C).  The rectal temperature 
remained in the normal range of 37.5°C±0.5°C for all rats.  Both MABP and HBR resided 
within their normal levels for all manipulation (Table 1).   
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Table 1. MABP and HBR measurement before and after temperature manipulation 
 
 
 As shown in the right diagram in figure 5, the blue curve shows the three-phase brain 
temperature manipulation. First, 29°C targeted temperature was achieved within 10 minutes 
and maintained for 20 minutes, then it rewarmed to 32°C within 10 minutes and maintained 
for another 20 minutes, and final rewarmed to 35°C and maintained for the rest 20 minutes. 
The rectal temperature keeps within the normal range during the whole period of time. 
 
2.3.2 Relationship Between Temporal Muscle Temperature and Brain Temperature 
 
Figure 5. The manipulation of brain temperature. Left, Five target temperature (39, 37, 35, 
32 and 29 ); Right, continuous manipulation of brain temperature from 29 to 32 and then 
to 35  (blue). 
 
 
 MABP mmHg HBR 
    Before After before After 
Rat1 (39°C) 76.0  80.0 367 372 
Rat2 (37°C) 76.5 72.5 388 375 
Rat3 (35°C) 70.0 70.0 367 372 
Rat4 (32°C) 77.0 73.0 370 340 
Rat5 (29°C) 74.8 71.5 381 337 
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 In this study, there is no consistent temperature relationship between temporal muscle 
and brain across animals. As shown in figure 6, the difference of temperature can be as low as 
2 , but also as high as 5 . If considering each animal individually, the difference is stable 
for as long as 90 minutes. Figure 7 shows a typical relationship between temperature in the 
temporal muscle and brain from one rat with a targeted temperature of 35 . The temperature 
difference is around 2.0 and is stable during the 120 minutes, 
 
 
Figure 7. The relationship between the temperature of temporal muscle and 
brain during a 90 minutes study 
30
31
32
33
34
35
36
37
38
0 20 40 60 80 100 120 140
T
 (
d
e
g
re
e
)
Time (min)
Temperature of brain vs. temporal muscle
Tbrain
Tmuscle
 
Figure 6. The temperature of the brain, temporal muscle and rectal under local cooling of 
the brain to 32 (9 rats totally) 
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2.3.3 Correlation Between T1 and Brain Temperature 
Spin-lattice relaxation time (T1) has been demonstrated to be linearly proportional to 
temperature when it is below 45°C [79-81].  Our results demonstrated that a highly linear 
correlation (y=0.011x-0.0003, R=0.94) exists between change of T1 and change of brain 
temperature (29°C-37°C) in the gray matter of brain, as shown in figure 8.  
 
 
This correlation can be utilized to obtain relative temperature maps in the brain. In this 
study, the temperature under a normothermic condition prior to any temperature manipulation 
is utilized as the reference temperature. The T1 maps prior to and after temperature 
manipulation can be derived by the TOMROP sequence.  A pixel-by-pixel brain temperature 
mapping can then be calculated using the relationship between T1 and temperature derived 
previously. 
 
2.3.4 Relationship Between CBF and Temperature 
2.3.4.1 Typical CBF Changes Under Normothermia Condition with MCAO Model 
Figure 8. Changes of relaxation T1 vs. changes of Temperature in the subcortical 
and cortical region 
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 A typical diagram of CBF under MCAO model is shown in figure 9. The CBF decreased 
immediately after the occlusion, remained stable during the occlusion and then recovered back 
to slightly below normal after reperfusion.  
 
2.3.4.2 CBF Under Hypothermia Condition with MCAO Model 
 
 
Figure 10. The changes of CBF with temperature in different region on 
normal rats 
 
Figure 9. Typical changes of CBF under MCAO 
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 The relations between CBF and the brain temperature under ischemia are shown in figure 
10. Cooling the brain always resulted in decreases in CBF at different regions. A highly linear 
relationship is observed between CBF and the brain temperature independent of the brain 
perfusion status. However, the rate of CBF reduction in response to hypothermia differed 
among different ROIs.  The CBF in the sham group (circle) drops most rapidly, followed by 
the contra region (triangles), mismatch region (squares) and the core region (diamonds).   
 
2.4 Conclusion and Discussion 
 The local brain temperature manipulation system can manipulate the brain temperature of 
rats quickly and accurately while at the same time, maintaining the body temperature and 
physiology parameters within normal range. The results showed that the targeted temperature 
was reached within 10 minutes and kept for long period of time (>90 minutes), with a small 
variation (less than 0.5 ). The system is also MR compatible to be used for MR scanning. 
 The efficiency of local cooling depends on both the temperature of the cooling water and 
the rate of water flow. For this device, the temperature of cold water was found to be the 
major factor that decides the cooling efficiency, while adjustment of the rate of water flow 
was utilized as fine adjustment. For each targeted temperature, different temperature of cooled 
water is manually preset (4  for 29  target temperature, 10  for 32  and 20  for 35  
). At the beginning of cooling, a high speed of water flow was used to initialize the cooling 
process. After the temperature is within 2  of the target temperature, the rate of water flow is 
decreased slowly to approach the target temperature. The brain temperature can be maintained 
within 0.5  of targeted temperature by fine adjustment of water flow.  
 Although surface local cooling reduces the side effects compared to the global cooling, 
such as shivering, arterial hypotension, etc., it induces temperature gradient within the brain. . 
The magnitude of the gradient depends on multiple variables, including tissue heat 
conduction, blood flow, body temperature, ambient air temperature, etc. In our study, in order 
to reach 29  deep inside brain, the surface of head has to be cooled to about 10 . Similar 
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result was reported by Abbot et al [84]. Given the temperature gradient within the brain tissue, 
our T1 based MR temperature mapping method will be used to measure the temperature 
distribution within the brain.  
 For this device, a thermo probe is required as the real time feedback signal. Since a direct 
measurement of brain temperature with a thermo-probe causes tissue damage and induces 
susceptibility artifacts in MR images, the temperature in temporal muscle can be utilized.   
Recent global cerebral ischemia and head injury rat studies have utilized this approach. 
However, the temperature in temporal muscle can differ from that in the brain, particularly 
during ischemia (57), (34). Moreover, surface cooling may cause a large temperature 
difference between the temporal muscle and brain. In our study, we found there temperature 
difference between temporal muscle and brain ranged from 2  to 5  across different 
animals. Two possible reasons may explain it.  Firstly, since there is a large temperature 
gradient under surface cooling, the temperature measurement is very sensitive to the position 
of the probe between temporal muscle and skull. A small difference in location may result in 
very different temperature measurements. Secondly, the space between the cooling coil and 
the head of animal might vary for different animals. Since air has high heat impendence, a 
small difference of the space will cause a large difference of temperature.  Nevertheless, 
although the temperature difference between temporal muscle and brain varies from animal to 
animal, it remains very stable for a long period of time for each animal.  This stable 
relationship motivates us to use temporal muscle temperature as the feedback control signal to 
keep the brain temperature stable for a desired period of time. Since MR method can be used 
to derive the brain temperature after data acquisition, we can classify the animals to different 
hypothermia groups according to their brain temperature maps at the later data analysis stage. 
 A highly linear relationship between T1 and local brain temperature was found in the 
study in normal rats, which can be utilized for measurement of brain temperature under 
hypothermia condition. One problem will happen if we want to apply the T1 map method to 
measure the temperature in stroke. Although there is no significant change of T1 reported 
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under a magnetic field <3T in the acute stage of stroke, a rapid increase of T1, as large as 
9%[85-88] within 10 minutes after occlusion was reported using a high magnetic field. 
Moreover, T1 continues to elevate for the next 60 minutes. This increase in T1 occurred 
immediately after stroke onset. Vasogenic edema that normally occurs a few hours or days 
after ischemia is not the primary reason.  Since the inflow of fresh blood may contribute to a 
faster apparent T1 recovery[89], one plausible explanation is that the decrease of blood flow 
may reduce the apparent T1.  However, the continued elevation of T1 within one hour after 
stroke cannot be explained since CBF remained stable during the same period of time. In 
addition, the maximum signal change caused by a completely stopped flow would be only 3% 
based on an analytical calculation.  Another possible reason is the rapid increase of 
temperature which induces an increase of T1 after the onset of stroke. While it has been 
reported that the temperature in the ischemic region decreases, since the reduction of the 
blood flow[90] blocks the warm blood from entering the ischemic region. However, on the 
other hand, blood flow also carries away the heat generated by tissue metabolism and a 
reduced blood flow may result in a local increase of temperature.  Thus far, the exact 
mechanism why T1 increases acutely is not known.  The pathological induced T1 increase 
may confound the measurement of brain temperature. Assuming the temperature distribution 
within the brain is symmetric across hemisphere, the T1 measurements from the contralateral 
unaffected hemisphere will allow a brain temperature mapping.    
 A highly linear relationship between CBF and brain temperature was found in our study. 
The local cooling to produce hypothermia in the rats consistently reduces CBF in normal 
region. This finding is consistent with that previously reported by Laptook, A. R. et al[84].  
They reported that the decrease of temperature about 4  (body cooling) resulted in a 
reduction of 40% of CBF of control. In our study, a similar result was observed; a 40% 
decrease of CBF leads to a temperature drop from 37  to 33  with surface cooling. 
 A highly linear relationship between CBF and temperature was also observed in the 
infarct region. However, the rate of CBF reduction differs under different severities of 
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occlusion.   Although many physiological possibilities may account for the observed different 
relations between CBF and the brain temperature, it is plausible that the status of 
autoregulation plays a critical role on how CBF will respond to brain temperature 
manipulation; the autoregulation is dysfunctional in the core area while may be slightly 
impaired in the mismatched regions, leading to different CBF characteristics in responses to 
temperature manipulations.  More studies are needed to further investigate whether or not 
brain metabolism under hypothermia also responds in a similar manner as that of CBF. 
 
  
 
 
 
 
CHAPTER 3 
R2’ MEASUREMENT AND ANALYSIS OF MULTIPLE MR 
PARAMETERS IN MCAO 
 
 
3.1 Theory: the Related MR Principles 
3.1.1 Introduction of DSC Method to Measure CBF 
 Perfusion measurements by Dynamic Susceptibility Contrast (DSC) magnetic resonance 
imaging utilize very rapid imaging (most commonly Echo Planar Imaging (EPI)) to capture 
the first pass of intravenously injected paramagnetic contrast agent - bolus tracking. By kinetic 
analysis, hemodynamic parameters, such as Cerebral Blood Flow (CBF), Cerebral Blood 
Volume (CBV), and Mean Transit Time (MTT), can be derived. 
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 Assuming a linear relationship between concentration of a high magnetic susceptibility 
contrast agent and change in transverse relaxation ( ) in dynamic susceptibility contrast-
weighted (DSC) MR imaginings[91], the change in concentration over time during the 
passage of a bolus of contrast agent in a volume of tissue can be characterized as: 
            (3.1) 
 where 0S  
is the baseline MR intensity, and )(tS is the signal intensity over time. 
Typical concentration curves after ischemic stroke are shown in figure 11.  
 By defining the residue function R(t) as the fraction of tracer remaining in the system at a 
given time t, the concentration of tracer within the voxel of tissue as can be modeled as  
        (3.2) 
 where is the Arterial Input Function (AIF) and  is the tissue blood flow. The AIF 
is typically measured directly from the MR images within an arterial vessel.  can then be 
estimated using deconvolution with the measured , which is often performed using the 
Singular Value Decomposition (SVD) method[92].  
 The equation (3.2) can be expressed in a discrete format: 
Figure 11. The dynamic concentration curve of the DSC method 
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          (3.3) 
 where  is the sampling interval and expanding equation into matrix notation, the 
deconvolution problem can be formulated as an inverse matrix problem, 
   (3.4) 
 Simplifying the above equation to  , one can solve for b, which is R(t) scaled by 
. By decomposing , where U and V are orthogonal matrices and S is a 
nonnegative square diagonal matrix, the inverse can be expressed as  where 
W=1/S along the diagonals, and zero elsewhere. Values of W corresponding to values where S 
is less than a preset tolerance threshold  are set to zero. The residue function 
scaled by  and b, can then be estimated by , and rCBF is estimated as 
b’s maximum value. 
 
3.1.2 The Blood-Oxygen Level Dependent (BOLD) Related Concepts  
 
3.1.2.1 Paramagnetic, Diamagnetic and Ferromagnetic 
 
An atom with an unpaired electron has a nonvanishing permanent magnetic moment with 
an associated nonzero dipole magnetic field, and is referred to as ‘paramagnetic.’ While these 
moments would be randomly distributed in the absence of outside interaction, it tends to align 
with an external magnetic field, producing a bulk magnetic moment and a corresponding 
macroscopic magnetic field augmenting the external field.  
Whether or not there are any permanent magnetic dipole moments, all materials will 
introduce dipole moment in the presence of time-dependent external magnetic fields. This is a 
much weaker effect than paramagnetism, and is called ‘diamagnetism.’ In those cases where 
the electrons pair up to cancel their spin magnetic moments, diamagnetism dominates the 
effect. In diagmagnetism, the macroscopic sum of the induced moments is roughly anti-
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parallel to the external magnetic field, and its macroscopic field opposes weakly the eternal 
magnetic field. 
Certain materials have permanent domains of electron spin magnetic moments which 
continue to produce a very strong macroscopic field independent of the external magnetic 
field. The domains are randomly distributed throughout the material unless there is an 
external field. When they are aligned by the temporary application of an external field, a 
permanent macroscopic magnet is produced. Iron oxide particulates are an example of such 
super paramagnetic materials. Thanks to the large local fields created, ferri oxide or iron 
particles are used as a contrast agent to produce signal loss in regions where they are 
deposited or to which they have migrated. A single particle can affect the signal in a volume 
millions times larger than the original particle volume. 
Blood can be approximated as a two-compartment system containing both plasma and 
red blood cells. The fraction of the volume of packed red blood cells to the volume of whole 
blood is called the hematocrit (Hct), which is typically about 0.4 (40%). 
It is well known that as oxygen content in blood changes so does the local susceptibility 
in the blood. The source of this has been shown to be the unshielded iron in hemoglobin (red 
blood cells). Much of the iron in the blood is in the hemoglobin, or more specifically, in one 
of two states, oxyhemoglobin or deoxyhemoglobin. These two states differ in their magnetic 
properties. Oxyhemoglobin is diamagnetic with no unpaired electrons. A deoxyghemoglobin 
molecule has unpaired electrons and is paramagnetic. The different magnetic properties 
between these two provide a potential contrast depending on blood oxygenation level, which 
is called Blood oxygenation level dependent (BOLD) contrast. 
In the brain, the blood vessels can be seen as a network of long cylinders (compared to 
the radius) with random orientations. Yablonskiy and Haacke [93] proposed an analytical 
model characterizing  MR signal without intravascular signal contribution. The MR signal can 
be written as below, 
         (3.5) 
 where  
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       (3.6) 
 where  is the spin density,  is the volume fraction,  is the processing frequency in 
the magnetic field, t is the signal decay time, and  is the zeroth order Bessel function. If one 
assumes that the arterial blood is fully oxygenated, then the  can be further derived from
           (3.7) 
 where  is the gyromagnetic ratio, which equals to  ;  is the 
fractional hematocrit;  is the main magnetic field strength;  is the susceptibility 
difference between fully oxygenated and fully deoxygenated blood which has been measured 
to be 0.18ppm per unit  in cgs units; and OEF is the oxygen extraction fraction. 
Based on their model, the relaxation R2′ is linearly proportional to OEF and can be 
written as follow[94]: 
 .2 OEFR              (3.8) 
 
 
 
 
A two dimensional, multi-echo gradient/spin echo sequence can be used to acquire 
images. As shown in figure 12, 45 echoes, with echo spacing 1.79 ms, are acquired after 
 
Figure 12. GESSE sequences diagram 
35 
 
RF pulse. The spin echo occurs at the middle of the 7th and 8th echo, which is 
optimized for calculation of R2’ (see results section for detail). The R2 were calculated by 
using the 7 symmetric pairs of echoes around the spin echo. After removing the R2 
component from the signal, the R2’ and  can be estimated by fitting the images using the 
analytical model with a matching filter method. 
 
 
3.1.3 Correction of Motion 
 
The bulk motion of an object during data acquisition causes an inconsistency in phase 
along the phase encoding direction which results in ghosting artifact in the image. An 
approach which combines pulse sequence design and post processing has been proposed by 
Ordidge et al.[95]. In this approach, a two echo-pulsed gradient spin-echo (PGSE) experiment 
is performed. The first echo, which is called navigator echo, is not phase encoded, while the 
second echo, the imaging echo, is phase encoded in the usual manner. Both the navigator and 
regular echoes contain the same undesirable effects of patient motion. Since there is no phase 
encoding gradient for the navigator echo, ideally, any variation of phase of the navigator echo 
from one phase encoding line to another is due to the motion. Thus, this motion-induced phase 
error, relative to the reference phase encoding line, can be found by subtracting the phase of 
the reference encoding line from other phase encoding lines.  Then these phases differences 
can be added back to the image echo of each encoding line and thus correct the motion.  
The k-space signal can be described as below[96, 97], 
        (3.9) 
 where m(x,y) is the spatial distribution of magnetization and  and  are the k-space 
spatial frequency terms which are proportional to the gradients  and , respectively. The 
navigator echo is obtained by acquiring the echo without a phase encoding gradient,  
      (3.10) 
 When a rigid-body motion occurs along the phase encoding direction during image 
acquisition, an extra phase term is added to each k-space line along phase encoding as below, 
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          (3.11) 
 where the phase difference can be calculated with the navigator echoes, 
        (3.12) 
 where  is the phase of a complex signal. 
 There are 45 image echoes in the GESSE sequence, with the longest TE  acquired at 90 
ms. One navigator echo at the beginning of the sequence cannot represent all the phase 
variation, especially at the longer TE echoes. To solve this problem, four addition navigator 
echoes were added after all image echoes, as shown in figure 12. The phase variation of each 
image echo was determined by linear fitting of the phase differences of the 5 navigator echoes. 
 
3.1.4 Correction of Static Magnetic Field Variations  
 
 The B0 field inhomogeneity is the source of distortion in both SE and GE sequences and 
signal loss in GE sequences, which usually occurs in regions of the brain adjacent to air 
cavities such as in the frontal orbital or lateral temporal areas. The susceptibility-induced B0 
inhomogeneity is proportional to the magnitude of the magnetic field. Although a higher 
magnetic field increases the sensitivity for studies that utilize the mesoscopic B0 
inhomogeneity, e.g. fMRI and OEF, the susceptibility effect from high macroscopic B0 
inhomogeneity also becomes more apparent.  
 In general, the B0 inhomogeneity is linear or at a low order. Since in MRI, the dimension 
along z direction is usually larger than the other two directions, it usually has the largest 
intravoxel phase dispersion along the z direction. Thus, in the following sections, only the 
susceptibility-induced gradient along z direction is considered. 
 A double echo 3D gradient echo sequence can be used to calculate the B0 inhomogeneity. 
The difference of disturbed B0 field from the original B0 field (dB) induces an additional 
phase, which is proportional to the B0 inhomogeneity and the echo time TE. To derive the 
magnitude of the B0 inhomogeneity, the subtraction of the phases of the two echoes can be 
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utilized. Usually the complex division method is preferred to reduce the phase wrap 
problem[98]. 
 )./()))exp((*)exp(( 1122 TEiCconjugateiCangleB      (3.13)  
 where  is the echo time difference between the two echoes.  
 Several methods have been proposed to correct the B0 field inhomogeneities. Basically, 
these methods can be categorized into five categories. The comparisons of these methods are 
shown in table 2. 
 
 
 Summary cons 
Thinner 
slices/higher 
resolution 
Excitation of thinner 
slice thickness 
Extreme small thickness are needed 
Compromised SNR 
Longer acquisition time or Reduced spatial 
coverage 
Higher hardware requirement(Gradient, RF 
pulse) 
Tailored RF 
pulse 
Application of 
quadratic phase of RF 
pulse, added to the 
linear phase produced 
by B0 inhomogeneity 
Low SNR (1/2 of original SNR) 
Need careful calculation  and specific design of 
RF pulse 
Passive 
shimming 
Induce additional dB 
field to compensate 
the susceptibility 
induced B0 
inhomogeneity with an 
additional diamagnetic 
material 
Low consistency 
Hard to control 
Post processing 
method 
Use known B0 
distribution to correct 
the signal decay curve  
 Need pre acquisition of B0 map 
Won’t work for high B0 inhomogeneity 
z-shimming 
method 
Application of 
gradient table on z 
direction 
 
Lower SNR 
Reduced the temporal resolution to 1/N 
 
 
 The method of Gradient Echo Slice Excitation Profile Imaging (GESEPI) was proposed 
by Yang et al[99] to correct B0 inhomogeneity. In the conventional 2D gradient echo 
Table 2.  Comparison of different B0 inhomogeneity correction methods 
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sequence, the image intensity is in the center of k space along the  direction ( ). With 
the susceptibility induced linear gradient along z direction, the magnetization distribution 
along z is as below, 
 )...exp(*)()( zTEGzizMzMTE          (3.14) 
 where Gz is the susceptibility-induced gradient and TE is the echo time. Based on FFT 
shift theory, the signal maximum will shift to a new position ( KnewKz  ) in k space as 
below 
 )())...exp(*)(())(( KnewkzMzTEGzizMFzMTEF      (3.15) 
 
TEGzKnew ..
2


            (3.16) 
 Thus, the conventional 2D acquisition, which only acquires the signal at 0zK  will 
miss the signal peak and further induce loss of signal. To compensate this shift of peak, an 
additional gradient cG  with the same magnitude as zG  but opposite sign can be applied for 
compensation. This addition cG  moves the signal peak from the position  back to 
0zK , thus recovers the signal losses. In the GESEPI method, instead of applying one 
addition gradient along the z direction, a table of compensation gradients was applied, 
resulting in acquisition of a series of 2D images, with each image has a different amount of 
compensation effect. A FFT is applied along the z direction and multiple images in spatial 
domain were calculated. The final output image is calculated by the sum of the multiple slices 
within the same slice thickness as the conventional GE sequence.  
 The shift of the signal peak is proportional to the susceptibility induced gradient zG and 
the echo time. To compensate the largest shift of signal peak, the maximal compensation 
gradient in the gradient table should be no less than lastz TEG * , 
 lastTEGztcGc *max*             (3.17) 
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 where maxcG  is the magnitude of the maximal compensation gradient and ct  is the 
duration of compensation gradient table. 
 
3.2 Methods 
3.2.1 Consistency Test Protocols 
 A phantom study was performed to test the effect of z-shimming method. A phantom 
with air bubble inside was inserted into the bore of a 9.4T scanner. As shown in figure 13, a 
revised gradient echo sequence (TR/TE:80ms/2.81ms) was utilized to acquire the data, with a 
compensation gradient table added on the slice selection direction (z-shimming). Sixteen steps 
of compensation gradient were applied, with shimming FOV 3.2 mm and excitation slice 
thickness 1.6mm. The excitation slice was chosen along the axial direction, with 20mm 
distance from the air bubble. The center slice of the 16 slices (Kz=0) and the combined image 
(average of center 8 slices of the 3rd dimension FFT reconstructed magnitude image) were 
compared. 
 
 
 
Figure 13. Multiple Gradient Echo sequence with z-shimming 
method 
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 To test consistency of the R2’ measurements of the method, 6 normal rats were scanned 
with the GESSE sequences with z-shimming and motion correction applied. The sequence 
protocol is shown in figure 14. A optimized 2D multi-echo gradient echo sampled spin echo 
(GESSE) sequence was used to acquire 50 echoes to estimate R2′ . Navigator echoes were 
added for motion correction. All 50 echoes were equally spaced with an inter-echo spacing of 
1.79ms, with the 7th and 8th echo symmetrically placed around where the true spin echo may 
occur. Field of View (FOV) and matrix size were set to 30x30 mm2 and 96x96, with a slice 
thickness of 1mm. The repetition time (TR) and echo time (TE) of the first echo were 2000 ms 
and 17.91 ms. A compensation gradient table was added on the slice selection direction, with 
shimming FOV is 2.0mm and step number is 6. 
 
 
 As shown in figure 15, totally 12 ROIs with 4x5 voxels each, are defined in the cortical 
and subcortical areas in both hemispheres symmetrically. The standard deviations of the mean 
value of each ROI across all the animals were calculated and used to measure the consistency 
of the method.  
 
Figure 14. The GESSE sequence for measurement of R2’ 
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 All MR images were acquired on a Bruker Biospec 9.4T small animal MR scanner 
(Bruker Medizintechnik, Karlsruhe, Germany) with a surface coil.  Field map shimming was 
utilized to minimize the background magnetic field inhomogeneities.  CBF was acquired with 
a DSC method. 4 doses (0.25ml/300g) of Gadolinium were injected through a tail vein. The 
images were acquired continuously by an Echo planar imaging (EPI) sequence (TR/TE, 
300ms/9.3ms; FOV, 30x30mm; matrix, 96x96; Repetition, 120) with temporal resolution 0.6s. 
ADC was computed from diffusion weighted images (DWI) acquired with a single-shot spin-
echo EPI sequence (TR/TE, 2500ms/100ms; FOV, 30x30mm; matrix, 96x96, two b values: 
b=0 and 1000 s/mm2 applied in three orthogonal axes).  In addition, T2 weighted (T2w) 
images were obtained with a Rapid Acquisition Relaxation Enhanced (RARE) sequence with 
nine slices (TR/TE 3000ms/40ms; RARE factor, 10; FOV, 30x30mm; matrix, 192x192). The 
GESSE sequence is the same as described in the previous section of consistency testing. 
 GESSE, CASL, DWI and T2w sequences were acquired during acute MCAO 
immediately followed by a reperfusion. Another T2w images were acquired at the 24 hours 
after MCAO to identify final infarct. 
 For the R2’ measurement sequence, I made the following improvement in my sequence 
for motion correction. One navigator echo without phase encoding was added before all the 
image echoes and another four navigator echoes were placed after the final echo. For data 
processing, a 1D inverse Fourier transform along readout direction was applied to both the 
Figure 15. The definition of the ROIs in subcortical (left) and Cortical (right) 
regions 
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navigator and regular echoes and translated the data into the hybrid domain (k domain along y 
direction and image domain along x direction). A point-by-point phase comparison was made 
between the reference line (48
th
 phase encoding line) and each of the rest of phase encoding 
lines. The phase difference for the navigator echo (1st, 47th, 48th, 49th and 50th navigator 
echoes) over time was fitted with a linear model. The phase differences of other image echoes 
between navigator echoes were derived by the linear relationship and added back to the image 
echoes. After all the lines were corrected, the inverse Fourier Transform was applied along the 
phase encoding direction for all the image echoes and the 2D images were reconstructed. 
 
3.2.2 R2’ measurement 
 The GESSE images were utilized to obtain R2′ maps as described in the theory part.  As 
a preprocessing routine,  navigator echoes were used to correct for motion artifacts. A 3x3 low 
pass filter was then applied to improve the signal-to-noise ratio (SNR).  R2 maps were 
calculated by fitting of the seven pairs of echoes symmetrically around the spin echo as 
described previously . Subsequently, the R2 decay term was removed from the images.  R2′ 
was then obtained with a numerical method (matched filter method)  based on an analytical 
signal model as shown in equation (3.5).  
 Finally, OMI_ R2′ was computed as the product of CBF and R2p as follows. 
 22_
 RCBFROMI            (3.18) 
 The 24hrs T2W images were registered to the T2W images at the acute stage with a rigid 
transformation for each rat using FSL 3.2 (FMRIB, Oxford, UK).  Three different ROIs were 
defined on the co-registered 24hrs T2W images. The INFARCT ROI was manually delineated 
as hyperintense regions in the ipsilateral hemisphere.  The MIRROR ROI was manually 
defined as the mirror counterpart of the INFARCT ROI in the contralateral hemisphere. The 
IPSI ROI and CONTRA ROI were manually defined to encompass the whole ipsilateral and 
contralateral hemispheres, respectively, without ventricles and white matter. The PERI ROI 
was then obtained by a subtraction of the INFARCT ROI from the IPSI ROI.  For all ROIs, 
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one pixel along the brain edge was excluded to minimize susceptibility and partial volume 
effects.  Moreover, in order to minimize the potential errors induced by mis-registration and 
noise induced spurious variations, isolated regions that are smaller than 1 mm3 were not 
included.  
The median value in the CONTRA ROI was utilized to normalize CBF (nCBF), ADC 
(nADC), OMI_ R2′ (nOMI_R2′) and R2′ (nR2′).  In the assessment of each normalized 
parameter in predicting tissue outcome, two pools of voxels were constructed.  The first pool 
(dead tissue) consisted of all the voxels from the INFARCT ROI and the second pool (alive 
tissue) consisted of roughly equal number of voxels randomly selected from the PERI ROI (if 
INFARCT ROI is greater than PERI ROI, some voxels were then randomly selected from the 
MIRROR ROI).   This procedure is necessary for an optimized prediction power.  To improve 
statistical power, data from all animals were pooled together.   ROC analysis was then 
performed for each parameter. The area under the ROC curve (AUC) was used to evaluate the 
prediction performance of each parameter, with a higher AUC indicating a better prediction.  
ROC analysis was conducted 500 times to minimize a potential variation caused by the 
random voxel selection in constructing the live tissue pool and mean AUC was utilized. 
The scatter plot maps were drawn to demonstrate the relationship between CBF, ADC, 
OMI_R2’ and R2’, with all voxel in the ipsi hemisphere, excluding the WM and CSF regions. 
The ipsi hemisphere was divided into two regions manually, the dead region, which has high 
intensity in the registered T2w images, and alive region. The scatter plot and analysis are 
based on the two regions, separately. 
Histogram maps of CBF, R2’ and OMI_R2’ were obtained for the time points before 
reperfusion and after reperfusion from INFARCT, PERI and CONTROL regions. 
 
3.2.3 The decision of the compensation gradient 
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Experimental results showed that the largest susceptibility induced dB is around 0.05ppm 
at the edge of the brain. The following calculation is to decide the magnitude of gradient that 
should be used to compensate the dB at the longest echo time.  
For the R2’ measurement sequence, the last echo is the 45th echo from spin echo. The 
longest echo time interval from spin echo can then be calculated as 
msTE 79.1)5.745((   
The gradient needed to compensate the susceptibility induced gradient  
                 (3.19) 
where sec 321.0   is the duration of the compensation gradients, the maximal 
compensation gradient  is calculated as 
       (3.20) 
This maximal compensation gradient fulfills the requirement to compensate the largest 
phase dispersion at the longest echo time. The compensation gradient table has 6 steps, 
resulting in a FOV of 2 mm in the z direction.  
 
3.3 Experimental Results 
3.3.1 Correction of Motion Artifact 
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 In figure 16, the relative phase differences between phase encoding lines 1 and 96 to line 
48 (reference phase encoding line) were plotted as a function of the echo number (1
st
, 46
th
-
50
th
). As shown in the figure, the phase difference varies at different echo.  
For motion correction, a linear fitting was utilized to obtain the relative phase for the echoes 
between the first and last four navigator echoes. The derived phase difference was then 
applied back to the imaging echoes to correct for motion artifact. 
 An example of motion correction was shown as below. 
Figure 16. The phase differences between phase encoding lines (1(blue), 
95(black) and reference phase encoding line 48(red), at different navigator 
echoes (1
st
 and 47
th
-50
th
) 
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 The R2* weighted images and their corresponding R2’ images before and after motion 
correction were shown in figure 17. An obvious ghost was found at the edge of FOV, because 
the inconsistency of phase induced by the motion across phase encoding lines. With motion 
correction the phase inconsistency was corrected and the ghost image becomes much smaller. 
The derived R2’ map after motion correction is smaller than that before correction. Since 
motion induces larger signal decay at long echo times when compared to these acquired at a 
shorter echo time, R2’ is overestimated in the presence of motion. An effective motion 
corrected method will reduce R2’ as shown in our results.   
 
3.3.1.1 Optimization of GESSE Sequences 
 The variance of the calculated R2’ depends on several factors, including the time space 
between echoes, the spin echo time, etc. To get optimized sequence parameters for the 
measurement of R2’, Monte Carlo method was used to simulate the result considering the 
following physiology conditions, R2=24 - 27Hz, R2’ = 4.061 – 20.305Hz, corresponding to 
OEF=0.20 – 1.00, and SNR=28 (from experimental results). The other sequence parameters 
are echo number =45, dTE=1.79ms, and TR=2000ms. 
Figure 17. The R2* weighted images (bottom) and their corresponding R2’ images (top) 
before (left) and after (right) motion correction 
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 The simulation results are shown in figure 18. For R2=27Hz (24Hz), the minimal STD 
for R2’ occurs at std_6 and std_7, with an STD of about 0.9Hz (0.75Hz). Thus, the parameter 
with 7 pairs of echoes before spin echo was chosen for the optimal measurement of R2’. 
3.3.1.2 B0 Inhomogeneity Correction 
 
 
 
Figure 19. Phantom R2* weighted images before (left) and after 
(right) application of z-shimming method 
Figure 18. Upper row: R2 = 27Hz, lower row: R2 = 24Hz, x-axis is the number of echoes 
before the spin echo, indicating how many pairs of echoes were used for R2 estimation, 
y-axis is the std(Hz) of the estimation of R2’. The number in the legend is the true R2’ 
values used for simulation, corresponding to OEF=0.20 – 1.0. 
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 For the phantom study, the high B0 inhomogeneity region produced by air bubble shifts 
the signal peak away from Kz=0, which leads to signal loss (low signal in the left image, 
figure 19).  The shifted peak was sampled by additional gradients with the z shimming method 
and the signal was then recovered by the application of FFT along z dimension (right image, 
figure 19.  
 
 
To determine the magnitude of z shimming gradients, an estimation of the magnitude of 
dB is necessary. As shown in figure 20, dB maps from 5 normal rats were acquired with a 
double echo/gradient echo sequence. With the field map shimming method on the Bruker 
system, a pretty uniform B0 field was obtained in most regions of brain. The B0 
inhomogeneity is higher at the edge of brain, with dB value around 0.05 ppm. The magnitude 
of compensation gradient and the steps of gradient table are derived based on equation (3.16) 
and (3.17). 
 
 
 
Figure 21. From left to right are the R2* weighted images before, after application of z-
shimming method, typical behavior of one voxel within high B0 inhomogeneity region( 
before (blue) and after (red) application of z-shimming method) and the corresponding 
dB map. 
 
Figure 20.The dB map from 5 normal rats after careful field map shimming using a 
9.4T Bruker Scanner. The scale of colorbar is 0.0ppm – 0.1ppm within 1mm 
thickness. 
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 To realize the z-shimming method, a gradient table was applied along the z direction on a 
multiple gradient echo sequence. Two normal animals were scanned and the R2* map was 
derived. As shown in figure 21, the high R2* region before applying z shimming corresponds 
to the high dB region. The blue curve is the signal curve as a function of time in the high B0 
inhomogeneity region. Since the R2* value was derived by a linear fitting of the logarithm of 
signal curve (blue), the fast decay results in a high R2* value. After the application of z-
shimming method, as shown by the red curve, a much smaller decay was found, which gives a 
more accurate estimation of the R2* value.  
 
3.3.1.3 Consistency Test  
 
 
 
 To test the consistency of our method to measure R2’, 6 normal rats were scanned, with 
12 ROIs defined in the cortical and subcortical regions. As shown in figure 22, the mean value 
of R2’ is about 5 – 8 Hz in the subcortical region, while is 4 – 8 Hz in the cortical region.  
 In the subcortical area, the STD of R2’ is less than 1.4Hz, while in the cortical area, the STD 
of R2’ is a little bigger, with a value below 2.1Hz.  
 
Figure 22. The STD values of mean of each ROI in subcortical (left) and 
cortical (right) regions 
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 The stroke study was performed using a 45 minute MCAO model. As shown in figure 23, 
a representative data set from an animal subjected to transient MCAO was shown. From left to 
right are CBF, R2’, OMI_R2’, ADC maps right before reperfusion and the corresponding 
registered T2w image at 24 hours after occlusion. After stroke, reduction of CBF was found at 
the occlusion side of the brain, while an increase of R2’ was found in the same region, with a 
decrease of ADC at the same time.  
 
 
 
 
Figure 23. Typical MR images before reperfusion 
    CBF              R2’             OMI_R2’           ADC               T2w 
Figure 24. Red: the lesion; Blue: the region outside lesion within the same 
hemisphere. a) nOMI vs. ADC; b) nR2p vs. ADC; c) CBF vs. ADC. 
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 The fates of ischemia tissue in the nOMI-ADC, nR2’-ADC and CBF-ADC were 
analyzed on a pixel-by-pixel basis. Figure 24 shows the scatter-plot of all the pixels from all 
animals in the ipsi-hemisphere. The hemisphere was subdivided into 2 groups based on the 
final T2w images, dead region and live region. In the CBF-ADC scatter plots, using threshold 
CBF=40ml/100g/min and ADC=800e-5mm2/s, the pixels in alive region can be further 
divided into 4 groups, with high CBF and high ADC(HH), high CBF and low ADC(HL), low 
CBF and high ADC (LH) and low CBF and low ADC(LL). Most pixels are in the HH and LL 
regions, while some pixels are in the other two regions. For the infarct region, all the voxels 
are within the LL region. 
 Figure 25 shows the scatter plots of nR2’-CBF from all animals. For the voxels in peri-
lesion region, a negative pattern between R2’ and CBF was observed, which indicates the 
increase of oxygenation with the reduction of CBF for the viable tissue. For the voxels in 
lesion region, there is no such pattern. 
 
Figure 25. nR2p vs. CBF. Red: the lesion; Blue: the region outside 
lesion within the same hemisphere  
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 For stroke rats, three ROIs were defined, including lesion, peri and contra. The 
histograms of CBF, R2’ and ADC for voxels in these three regions are shown in figure 26. For 
CBF, the values are clearly separated between three ROIs , with the smallest CBF in lesion 
region, while larger in peri region and largest in contra region.  The R2’ is high in both the 
lesion region and peri region with a similar value (1.3Hz -1.7Hz) compared to the contra 
region (0.8Hz-1.3Hz). For the OMI_R2’, the value in the peri region is similar to contra 
region, while much lower in the lesion region. After reperfusion, the CBF, R2’ and OMI_R2’ 
all return back to the same level as the contra region.  
 
3.4 Conclusion and Discussion 
 The navigator echoes method was used for correction of motion artifacts. In our study, 
oral intubation was used to control the breath of animals. Teeth bar and ear bar were used to 
fix the head of animal, thus suppressing the motion. In most cases, the motion artifacts can be 
suppressed well.  
Figure 26. The histogram of CBF, R2’ and OMI_R2’ before and after 
reperfusion. The 25
th
, 50
th
 and 75
th
 percentile maps are shown in the third 
column. 
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 There are several methods to correct for the B0 inhomogeneity. As shown in table 2, five 
different methods are listed. Each method has its own shortcomings. The z-shimming has a 
lower SNR, although it does not need the prior knowledge of the B0 inhomogeneity field or 
careful design of RF pulse.  
 The consistency of R2’ is good in the subcortical region (STD<1.4Hz), while is larger 
(STD<2.1Hz) in the cortical region.  The possible reason for the high variance of R2’ in 
cortical region is because the cortical region is at the edge of brain, where there is a relatively 
higher dB effect. Although Z-shimming method was utilized to correct for the B0 
inhomogeneity, it is possible that in certain animals, the dB effect is too big to be 
compensated for the applied gradients. Thus, the variance across animal was larger due to the 
different compensation effect on difference animals. 
 There are other ways to measure R2’, such as the acquisition of R2 with a multi spin 
echo sequence and R2* with a gradient echo sequence separately, then the subtraction of the 
two is used to derive the R2’. The disadvantages of this method include the relatively long 
acquisition time of two sequences, making the temporal resolution low, which did not fulfill 
the dynamic requirement in acute stage of ischemic stroke. In addition, the diffusion effect is 
different in R2 and R2* sequences, which induces biases and makes the R2’ overestimated. 
Geisler et al examined R2′ in the regions with apparent diffusion coefficient (ADC) lesion, 
lesion growth (recruited in the final lesion but without acute ADC abnormality) and surviving 
tissue .  They observed an elevated R2′ in the ischemic hemisphere when compared to the 
unaffected hemisphere.  Moreover, the ADC lesion exhibited the highest R2′, followed by the 
lesion growth and surviving tissue regions.  Their observation suggested that an increase of 
R2′ may correspond to an increase of OEF in ischemia.  In our study, the increase of R2’ was 
also observed in both the infarct region and the peri-infarct region, but there is no significant 
difference between these two regions. The possible reason is that the subjects in our study are 
rats, which might have different physiology responses to ischemic stroke compared to human. 
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For example, in our study, the final lesion is smaller than the ADC lesion in rats, while it is 
usually larger than the ADC lesion as shown in Geisler’s study in human. 
 From the histograms, the CBF can be used to separate the lesion, peri and contra regions 
well. Interestingly, although the OMI_R2’ doesn’t show better separation between lesion and 
peri regions compared to CBF, there is no significant difference between peri and contra 
region. The possible reason is, that the high R2’ value in the peri region indicates an increase 
of oxygen extraction, thus the increase concentration of deoxy-Hb. Since OMI_R2’ is the 
product of CBF and R2’, the high R2’ compensates the reduction of CBF, thus makes the 
OMI_R2’ similar to the contra region, indicating the maintained normal metabolism of tissues 
in peri-lesion region. Nevertheless, for the dead region, the high R2’ is unexpected. A 
generally held view is that dead tissue does not consume oxygen and R2’ should be low 
instead of high in these regions.  The concentration of deoxy-Hb is determined mainly by two 
factors: the product of deoxy-Hb, and the transportation of deoxy-Hb out of the tissue.  
Immediately after stroke onset, oxygen extraction fraction will increase to maintain neuronal 
function, resulting in an increase of deoxy-Hb.   In same region with a severe reduction of 
CBF, the generated deoxy-Hb might not be removed effectively, which causes an 
accumulation of  deoxy-Hb and thus the increase of R2’. Another plausible reason is that cells 
were still alive at the moment of imaging, but died later after reperfusion due to delayed 
neuronal death. Further studies are needed to fully understand this phenomenon.  
  
 
CHAPTER 4 
FUTURE WORK 
 
 
 We have developed a local brain temperature manipulation system and the MRI methods 
to measure the brain temperature. Moreover, we studied the changes of physiology parameters 
using 45 minutes MCAO under a normal body temperature condition. Future work includes 
further verification and analysis of these data which may shed light on the underlying 
mechanisms behind these changes.  In addition, we will use different durations of MCAO to 
study whether the findings depend on elapsed times after stroke.  Finally, we will study how 
hypothermia may alter the course of ischemic progression using these physiological 
parameters.   
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